Rathan Kumar

CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model

M. Karunasiri, Olimjon Toirov, Parvathi Ranganathan, 2024, Blood advances.